Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $140.32 | 10 | 92.2% |
| Education | $11.90 | 1 | 7.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $66.21 | 4 | $0 (2020) |
| Supernus Pharmaceuticals, Inc. | $49.62 | 4 | $0 (2018) |
| Amarin Pharma Inc. | $13.27 | 1 | $0 (2019) |
| Eisai Inc. | $11.90 | 1 | $0 (2018) |
| Lilly USA, LLC | $11.22 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $66.21 | 4 | AstraZeneca Pharmaceuticals LP ($66.21) |
| 2019 | $13.27 | 1 | Amarin Pharma Inc. ($13.27) |
| 2018 | $60.39 | 5 | Supernus Pharmaceuticals, Inc. ($37.27) |
| 2017 | $12.35 | 1 | Supernus Pharmaceuticals, Inc. ($12.35) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/25/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/04/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/04/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/15/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/13/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/06/2018 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: Neuroscience | ||||||
| 10/15/2018 | Eisai Inc. | Belviq (Drug) | Education | Cash or cash equivalent | $11.90 | General |
| Category: Nutrition and Weight Loss | ||||||
| 05/22/2018 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $14.33 | General |
| Category: AED | ||||||
| 03/06/2018 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $11.66 | General |
| Category: AED | ||||||
| 01/24/2018 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $11.28 | General |
| Category: AED | ||||||
| 12/06/2017 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $12.35 | General |
| Category: AED | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 7 | 432 | 580 | $33,531 | $14,151 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 126 | 208 | $15,600 | $6,367 | 40.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 81 | 90 | $9,000 | $4,130 | 45.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 37 | 37 | $5,550 | $2,693 | 48.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 144 | 197 | $1,576 | $586.38 | 37.2% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 13 | 14 | $910.00 | $234.46 | 25.8% |
| 81002 | Urinalysis, manual test | Office | 2020 | 20 | 23 | $345.00 | $79.20 | 23.0% |
| 93005 | Routine electrocardiogram (ekg) with tracing using at least 12 leads | Office | 2020 | 11 | 11 | $550.00 | $60.76 | 11.0% |
About Dr. Robert Mitchell, M.D
Dr. Robert Mitchell, M.D is a Family Medicine healthcare provider based in Gardendale, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083785117.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Mitchell, M.D has received a total of $152.22 in payments from pharmaceutical and medical device companies, with $66.21 received in 2020. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($140.32).
As a Medicare-enrolled provider, Mitchell has provided services to 432 Medicare beneficiaries, totaling 580 services with total Medicare billing of $14,151. Data is available for 1 year (2020–2020), covering 7 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Gardendale, AL
- Active Since 11/12/2006
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083785117
Products in Payments
- FARXIGA (Drug) $66.21
- TROKENDI XR (Drug) $49.62
- Vascepa (Drug) $13.27
- Belviq (Drug) $11.90
- EMGALITY (Drug) $11.22
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Gardendale
Mrs. Kristi Lunceford, Crnp, CRNP
Family Medicine — Payments: $2,479
Joseph Brewer, Do, DO
Family Medicine — Payments: $1,155
Dr. Robin Conley, Do, DO
Family Medicine — Payments: $560.27
Sharon Gray, M.d, M.D
Family Medicine — Payments: $502.64
Dr. Paul Ward, Md/Mph, MD/MPH
Family Medicine — Payments: $276.66
Tianna Hall
Family Medicine — Payments: $206.90